Exogenous recombinant IGFBP7 treatment on M0 macrophages decreased the expression level of the biomarkers in M1 macrophages with a pro-inflammatory phenotype and increased the expression level of biomarkers in M2/TAM-like macrophages with a pro-tumor phenotype. This evidence concerns the gene IGFBP7 and neoplasm.